NPHS1 and focal segmental glomerulosclerosis: Pathogenic circulating anti-nephrin auto-antibodies have recently been implicated in disease pathophysiology, as they have been detected in 9% of patients with primary FSGS [8], and in all patients of a small cohort with post-transplant recurrence of FSGS [9].